Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4489PDF: 1804HTML: 1125 -
CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA Candidemia in acute Leukemia
1810PDF: 984HTML: 259 -
Osteolytic bone lesions – A rare presentation of AML M6.
2070PDF: 1193HTML: 8002Untitled: 224 -
-
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1508PDF: 977HTML: 258 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1213PDF: 1151HTML: 504 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1969PDF: 1054HTML: 251 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2557PDF: 1242HTML: 1085 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2681PDF: 853HTML: 5379 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1495PDF: 601HTML: 241 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2107PDF: 878HTML: 262 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3405PDF: 1021HTML: 3171flowcytometric result of peripheral blood sample: 215 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1903PDF: 779HTML: 484 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1479PDF: 1309HTML: 520 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2622PDF: 1770HTML: 601 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2582PDF: 827HTML: 1748 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1277PDF: 781Html: 120 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3699PDF: 1603HTML: 4506CoverLetter: 210Figure1: 231 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3881PDF: 1659HTML: 870Figures . Eliassian: 262 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1554PDF: 957Suppl. Files: 479HTML: 300 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13358PDF: 1026HTML: 7319 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1814PDF: 838HTML: 304 -
How I treat acute and persistent sickle cell pain
2087PDF: 1164HTML: 726 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1481PDF: 864HTML: 3143







